Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Cancer research and Breast cancer, with related work in Trastuzumab, Trastuzumab emtansine, Pertuzumab. Notable publications include 'Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer', 'Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer', and 'Sequence analysis of mutations and translocations across breast cancer subtypes'.
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Correlation of molecular alterations with efficacy of everolimus in hormone-receptor–positive (HR+), HER2-negative advanced breast cancer: Preliminary results from BOLERO-2.
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sequence analysis of mutations and translocations across breast cancer subtypes
PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma
Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, and Colon Exhibit Distinct Patterns of Genome Instability and Oncogenesis